House of Lords: medical marketing event

Join us on 22 March at the House of Lords for the next event from the Medical Marketing Group. Entitled, ‘Towards transparency: Evolving how we work with healthcare professionals’, this meeting will be of interest to anyone working in medical marketing or involved in compliance or corporate social responsibility.

Towards transparency:
Evolving how we work with healthcare professionals

22 March 2016
From 10:30 to 14:00

Committee Room 1
House of Lords
London
SW1A 0PW

       Westminster Station

Transparency, trust and therapies

How should we respond to society’s growing demand for greater transparency? This is one of the most pressing issues facing the pharmaceutical and medical technology industries today. Without the public's trust, the healthcare industry will face increasing pressures that will hinder the ability to provide safe, effective and valuable therapies. Hear from global player, GSK, about why the company has decided to take an industry-leading position, how it has managed the real-world issues and what other life science companies can learn from their experience.

About our speaker

Hear from Dr Stephen McDonough, Vice President Medical Director for GSK UK and Ireland, studied medicine at the University of Nottingham and worked as a physician in hospital and general practice for eight years. Stephen is a specialist in pharmaceutical medicine. During his 17 years in industry he has worked in UK, Ireland and in global roles in a variety of organisations from small biotech to large pharma. He has worked in medical affairs, research and development and health outcomes functions. He also has an MSc in Health Economics, Policy and Management from the London School of Economics and Political Science.